BIOSOL A/S
CVR number: 21122041
Landevejen 129, 5883 Oure
henrik.hougesen@gmail.com
tel: 62228333
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 005.21 | -44.31 | -34.88 | -30.05 | -30.15 |
| Employee benefit expenses | -1 213.04 | - 304.04 | - 295.18 | - 102.15 | |
| Other operating expenses | -29.04 | -0.15 | |||
| Total depreciation | -51.10 | -1.01 | |||
| EBIT | 712.02 | - 349.20 | - 330.06 | - 132.20 | -30.15 |
| Other financial income | 159.86 | 182.64 | 366.58 | 184.09 | 159.41 |
| Other financial expenses | -34.28 | - 211.06 | - 165.78 | - 650.85 | -52.99 |
| Pre-tax profit | 837.61 | - 377.62 | - 129.26 | - 598.97 | 76.26 |
| Income taxes | - 120.35 | 9.83 | -1.65 | -0.03 | |
| Net earnings | 717.25 | - 367.80 | - 129.26 | - 600.62 | 76.23 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current other receivables | 347.12 | 361.15 | 375.74 | 340.92 | 304.69 |
| Long term receivables total | 347.12 | 361.15 | 375.74 | 340.92 | 304.69 |
| Inventories total | |||||
| Current trade debtors | 55.33 | ||||
| Prepayments and accrued income | 23.53 | 3.64 | 3.79 | 3.44 | 3.07 |
| Current other receivables | 1 735.27 | 241.47 | 23.26 | 10.24 | 20.26 |
| Current deferred tax assets | 6.00 | 4.84 | 19.50 | 71.00 | 70.20 |
| Short term receivables total | 1 820.13 | 249.95 | 46.55 | 84.68 | 93.54 |
| Other current investments | 165.53 | 1 936.31 | 2 498.95 | 1 965.47 | 1 920.52 |
| Cash and bank deposits | 1 918.90 | 710.27 | 216.71 | 16.95 | 21.74 |
| Cash and cash equivalents | 2 084.43 | 2 646.59 | 2 715.66 | 1 982.42 | 1 942.26 |
| Balance sheet total (assets) | 4 251.69 | 3 257.68 | 3 137.95 | 2 408.02 | 2 340.49 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Shares repurchased | 126.40 | 130.74 | 134.63 | 139.43 | |
| Retained earnings | 2 371.15 | 3 088.40 | 2 589.86 | 2 325.97 | 1 585.92 |
| Profit of the financial year | 717.25 | - 367.80 | - 129.26 | - 600.62 | 76.23 |
| Shareholders equity total | 3 714.80 | 3 220.60 | 3 091.34 | 2 359.98 | 2 301.58 |
| Provisions | 9.83 | ||||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 30.72 | ||||
| Current trade creditors | 187.32 | 10.00 | 10.00 | 10.00 | 10.00 |
| Current owed to participating | 10.81 | ||||
| Short-term deferred tax liabilities | 108.88 | ||||
| Other non-interest bearing current liabilities | 200.13 | 27.08 | 36.60 | 38.03 | 18.10 |
| Current liabilities total | 527.06 | 37.08 | 46.61 | 48.04 | 38.91 |
| Balance sheet total (liabilities) | 4 251.69 | 3 257.68 | 3 137.95 | 2 408.02 | 2 340.49 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.